Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Georg

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Cell Reports. Medicine|August 20, 2025
Rewired type I IFN signaling is linked to age-dependent differences in COVID-19Lev Petrov, Sophia Brumhard, Sebastian Wisniewski, et al.
Nature|July 30, 2020
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19Julian Braun, Lucie Loyal, Marco Frentsch, et al.
Cell|July 4, 2024
The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulationRainer Knoll, Elisa T Helbig, Kilian Dahm, et al.
Cell|January 15, 2022
Complement activation induces excessive T cell cytotoxicity in severe COVID-19Philipp Georg, Rosario Astaburuaga-García, Lorenzo Bonaguro, et al.
Blood|April 14, 2026
Inhibition of high CXCR4 with Motixafortide and absence of single-cell MRD predict outcome after AML consolidationEnise Ceran, Sonia Jaramillo, Anne Kathrin Merbach, et al.
Cell|August 19, 2020
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell CompartmentJonas Schulte-Schrepping, Nico Reusch, Daniela Paclik, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Cell Reports. Medicine|August 20, 2025
Rewired type I IFN signaling is linked to age-dependent differences in COVID-19Lev Petrov, Sophia Brumhard, Sebastian Wisniewski, et al.
Nature|July 30, 2020
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19Julian Braun, Lucie Loyal, Marco Frentsch, et al.
Cell|July 4, 2024
The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulationRainer Knoll, Elisa T Helbig, Kilian Dahm, et al.
Cell|January 15, 2022
Complement activation induces excessive T cell cytotoxicity in severe COVID-19Philipp Georg, Rosario Astaburuaga-García, Lorenzo Bonaguro, et al.
Blood|April 14, 2026
Inhibition of high CXCR4 with Motixafortide and absence of single-cell MRD predict outcome after AML consolidationEnise Ceran, Sonia Jaramillo, Anne Kathrin Merbach, et al.
Cell|August 19, 2020
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell CompartmentJonas Schulte-Schrepping, Nico Reusch, Daniela Paclik, et al.
Pageof 3